Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea
· Delayed Price · Currency is KRW
9,350.00
+70.00 (0.75%)
At close: Apr 28, 2026
Pharos iBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 121,951 | 121,562 | 98,001 | 191,588 | - | - | |
| Market Cap Growth | 53.67% | 24.04% | -48.85% | - | - | - | |
| Enterprise Value | 103,882 | 112,925 | 80,945 | 164,210 | - | - | |
| Last Close Price | 9420.00 | 9390.00 | 7570.00 | 14830.00 | - | - | |
| PB Ratio | 8.76 | 8.73 | 5.27 | 6.76 | - | - | |
| P/TBV Ratio | 9.00 | 8.97 | 5.39 | 6.79 | - | - | |
| Debt / Equity Ratio | 0.57 | 0.57 | 0.01 | 0.01 | 0.02 | -0.04 | |
| Net Debt / Equity Ratio | -1.30 | -1.30 | -0.83 | -0.89 | -0.83 | 1.47 | |
| Net Debt / EBITDA Ratio | 1.69 | 1.69 | 1.32 | 2.67 | 1.47 | 2.88 | |
| Net Debt / FCF Ratio | 2.16 | 2.16 | 1.55 | 3.05 | 1.73 | 2.74 | |
| Asset Turnover | - | - | - | - | 0.01 | 0.00 | |
| Quick Ratio | 18.71 | 18.71 | 16.25 | 21.15 | 16.06 | 0.56 | |
| Current Ratio | 18.96 | 18.96 | 16.70 | 21.57 | 16.53 | 0.57 | |
| Return on Equity (ROE) | -66.11% | -66.11% | -44.97% | -38.50% | -1825.61% | - | |
| Return on Assets (ROA) | -29.06% | -29.06% | -31.94% | -26.12% | -28.73% | -23.78% | |
| Return on Capital Employed (ROCE) | -40.40% | -40.40% | -67.50% | -35.50% | -59.80% | 55.20% | |
| Earnings Yield | -8.82% | -8.85% | -10.78% | -4.62% | - | - | |
| FCF Yield | -6.86% | -6.88% | -10.21% | -4.31% | - | - | |
| Buyback Yield / Dilution | -0.14% | -0.14% | -6.81% | -36.26% | -53.03% | -2.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.